Development of an FhbB based chimeric vaccinogen that elicits antibodies that block Factor H binding and cleavage by the periopathogen Treponema denticola.

O'Bier, Nathaniel S; Patel, Dhara T; Oliver, Lee D; Miller, Daniel P; Marconi, Richard T

O'Bier, Nathaniel S; Patel, Dhara T; Oliver, Lee D; Miller, Daniel P; Marconi, Richard T.

Afiliación

O'Bier NS; Department Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, VA, USA.
Patel DT; Department Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, VA, USA.
Oliver LD; Department Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, VA, USA.
Miller DP; Department Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, VA, USA.
Marconi RT; Department Microbiology and Immunology, Virginia Commonwealth University Medical Center, Richmond, VA, USA.

Mol Oral Microbiol ; 36(1): 50-57, 2021 02.

Article en En | MEDLINE | ID: mdl-33219611

Asunto(s)

Treponema denticola; Vacunas; Proteínas Bacterianas/genética; Factor H de Complemento/genética; Péptido Hidrolasas; Treponema

Palabras clave

Treponema denticola; Factor H; FhbB; chimeric immunogen; dentilisin; periodontal disease

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas / Treponema denticola Idioma: En Revista: Mol Oral Microbiol Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google